歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁 > 小分子抑制劑 > Chromatin/Epigenetic > RG2833

瀏覽歷史

S80176

RG2833

MedMol 99%
  • 英文名:
  • RG2833
  • 別名:
  • N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide; UNII-17V14R89EU; RGFP 109; RG2833 (RGFP109); S7292; RG-2833;
  • CAS號(hào):
  • 1215493-56-3
  • 分子式:
  • C20H25N3O2
  • 分子量:
  • 339.43
  • 核磁/質(zhì)譜:
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購物車...
MedMol S80176-5mg 99% ¥190.00元 6 - - - EA 加入購物車
MedMol S80176-10mg 99% ¥315.00元 7 - - - EA 加入購物車
MedMol S80176-25mg 99% ¥612.00元 6 - - - EA 加入購物車
MedMol S80176-50mg 99% ¥850.00元 5 - - - EA 加入購物車
源葉(MedMol) S80176-100mg 99% ¥1360.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購物車
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說明書。
  • 產(chǎn)品描述: RG2833 is a brain-penetrant HDAC inhibitor with IC50s of 60 nM and 50 nM for HDAC1 and HDAC3, respectively. The Ki values for HDAC1 and HDAC3 are 32 and 5 nM, respectively
  • 靶點(diǎn): HDAC3:50 nM (IC50);HDAC1:60 nM (IC50);HDAC1:32 nM (Ki);HDAC3:5 nM (Ki);HDAC
  • 體內(nèi)研究:
    RG2833 (150 mg/kg) is able to correct frataxin deficiency in the brain and heart of KIKI mice 24 hours after a single injection, but not when lower doses are used. When followed in time, the frataxin mRNA increase induced by RG2833 in the KIKI mouse can be first detected at 12 hours and reach a maximum at 24 hours in both brain and heart. RG2833 (100 mg/kg, s.c.) is well tolerated in chronic dosing of mice without toxicity. RG2833 improves motor coordination of YG8R FRDA mice. RG2833 increases frataxin protein expression in the brain of YG8R FRDA mice. RGFP109 (30 mg/kg, p.o. once daily for 6 days) has no acute effects on dyskinesia after single or 6 days once-daily treatment. One week following cessation of RGFP109, dyskinesia and duration of ON-time with disabling dyskinesia are reduced by 37% and 50%, respectively
  • 參考文獻(xiàn):
    1. Rai M, et al. Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model. PLoS One. 2010, 5(1), e8825. 2. Sandi C, et al. Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model. Neurobiol Dis. 2011, 42(3), 496-505. 3. Johnston TH, et al. RGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept study. Parkinsonism Relat Disord. 2013, 19(2), 260-264.
  • 溶解性: DMSO  :  ≥  50  mg/mL  (147.31  mM)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.946 ml 14.731 ml 29.461 ml
    5 mM 0.589 ml 2.946 ml 5.892 ml
    10 mM 0.295 ml 1.473 ml 2.946 ml
    50 mM 0.059 ml 0.295 ml 0.589 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。